Seth Lewis

SVP, Investor Relations, Communications & Strategy at Molecular Partners

Seth Lewis is Senior Vice President, Investor Relations, Communications and Strategy of Molecular Partners. His work includes global communications, shareholder relationship management and external strategy. Prior to joining Molecular Partners, Seth was Head of IR and Communications at Surface Oncology (NASDAQ: SURF) where he was integral in establishing the company’s communications strategy. Prior to Surface, he served as Vice President of IR and Communications at Bavarian Nordic, a Danish-listed, live-virus vaccine developer. He began his career in biotech with the Trout Group (now Solebury Trout), a boutique investor relations and strategic consultancy. Seth obtained a B.A. in history from Hartwick College in Oneonta, NY.

Location

Acton, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Molecular Partners

3 followers

About Molecular Partners AG Molecular Partners AG is a clinical-stage biotech company that is developing a new class of therapies known as DARPin® therapeutics.


Industries

Employees

51-200

Links